SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-19-316242
Filing Date
2019-12-17
Accepted
2019-12-17 16:17:02
Documents
1
Effectiveness Date
2019-12-17

Document Format Files

Seq Description Document Type Size
1 S-8 POS d802809ds8pos.htm S-8 POS 24106
  Complete submission text file 0001193125-19-316242.txt   25153
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-229344 | Film No.: 191289909
SIC: 2836 Biological Products, (No Diagnostic Substances)